NeuroproteXeon Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Latest Deal Type
  • Bankr. Admin/​Reorg
  • Financing Rounds
  • 2

NeuroproteXeon General Information

Description

Provider of late clinical-stage pharmaceutical and medical devices.. The company's inhalation device protects against brain cell death following acute neurologic injury.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Therapeutic Devices
Primary Office
  • 50 Cobham Drive
  • Orchard Park
  • New York, NY 14127
  • United States
+1 (716) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NeuroproteXeon Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore NeuroproteXeon‘s full profile, request access.

Request a free trial

NeuroproteXeon Executive Team (6)

Name Title Board Seat Contact Info
Bill Burns Chief Executive Officer & Director
Jim McAuliffe Chief Financial Officer & Director
Matt Napoletano Chief Operating Officer & Director
Michelle Cullen Chief Accounting Officer
Mervyn Maze Co-Founder
You’re viewing 5 of 6 executive team members. Get the full list »